Senior Clinical Biomarker Lead (Part-Time 50%) | Senior Clinical Biomarker Lead in Teilzeit 50% (m/w/d)

FERCHAU GmbH Niederlassung Ulm

Biberach an der Riß, Baden-Württemberg, Deutschland
Published Apr 20, 2026
Full-time
No information

Job Summary

As a Senior Clinical Biomarker Lead, you will play a pivotal role in shaping biomarker strategies for translational and clinical research projects. You will act as the primary contact for multiparameter flow cytometry and advanced immunoassay technologies. Your day-to-day responsibilities include managing the end-to-end biomarker analysis process—from method development and fit-for-purpose validation to coordinating execution in clinical trials. You will also be responsible for reviewing and approving study documentation, providing expert methodological advice for experimental medicine, and ensuring all processes meet regulatory standards. This role is ideal for an experienced scientist looking to leverage their expertise in a high-impact, part-time capacity (50%). You will work within a professional environment that values structured, solution-oriented approaches and cross-functional collaboration. The position offers a unique opportunity to influence clinical study outcomes through rigorous analytical validation and strategic oversight in a dynamic research setting.

Required Skills

Education

PhD in a relevant scientific field (e.g., Molecular Biology, Biochemistry, Molecular Medicine, Biotechnology, Analytical Chemistry) or a Master's degree with extensive relevant professional experience.

Experience

  • Several years of professional or scientific experience in molecular biology, biochemistry, or related fields
  • Professional experience in clinical research and study projects
  • Practical experience with cellular and protein-based biomarkers in clinical environments
  • Experience with GCP-compliant workflows

Languages

German (Intermediate)English (Fluent)

Additional

  • Part-time position (50% / 18.75 hours per week). Valid work permit required for Germany.